Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led By Sdic Venture Capital
Round Type
Series C
GuangzhouManufacturingBiotechnologyInvestors
Description
On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding 300 million yuan. This round of financing was led by SDIC Venture Capital, with participation from Guangdong Technology Financial Group, Taipu Life Science Investment, and Chnin Financial. The funds raised in this round will be channeled towards advancing the company's R&D in novel biotechnologies, scaling commercial production capabilities, and expanding its global strategic footprint.
Quick answer
Canton Biologics raised an undisclosed amount in a Series C round, dated September 18, 2023. Investors: Chnin Financial, Taipu Life Science Investment, Guangdong Technology Financial Group and Sdic Venture Capital. Canton Biologics is based in Guangzhou, Guangdong, China.
- How much did Canton Biologics raise?
- Canton Biologics raised an undisclosed amount in a Series C round on September 18, 2023.
- Who invested in Canton Biologics?
- Chnin Financial, Taipu Life Science Investment, Guangdong Technology Financial Group and Sdic Venture Capital are named as investors in this round.
- What does Canton Biologics do?
- Canton Biologics is the biggest Contract Development Manufacture Organization in the South China, providing the one-stop integrated solutions that meet international regulatory standards and cover early discovery to..
- Where is Canton Biologics based and how big is it?
- Canton Biologics is based in Guangzhou, Guangdong, China.
- Who are the decision-makers at Canton Biologics?
- Fundz holds 1 contact at Canton Biologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Canton Biologics that raised within 45 days of this round, from Fundz verified event records.
- Genezen raised $19M (Private Equity) on November 2, 2023.
- TendoNova raised $250K on November 1, 2023.
- Gyre Therapeutics raised $5M on October 30, 2023.
- Montinutra raised $2.2M (Seed) on October 26, 2023.
- Planatome raised $6M on October 25, 2023.
- VitaTek raised an undisclosed amount (Series A) on October 22, 2023.
Who to call at Canton Biologics, and when
A new round usually means Canton Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Canton Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Canton Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Canton Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Canton Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Canton Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.